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Abstract The purification and functional reconstitution of the 
transporter associated with antigen processing (TAP) is crucial 
for a complete molecular understanding of its action. Here, we 
report the conditions for the successful solubilization of human 
TAP from cellular membranes while maintaining TAP peptide-
binding activity. In addition, solubilized TAP was incorporated 
into proteoliposomes and shown to possess specific peptide-
binding activity. These studies provide the foundation for future 
attempts to achieve the complete functional reconstitution of 
TAP, which includes peptide transport. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The transporter associated with antigen processing (TAP) 
plays a critical role in the major histocompatibility complex 
(MHC) class I antigen presentation pathway. TAP transports 
antigenic peptides from the compartment in which they are 
made, the cytosol, into the lumen of the ER, where they can 
associate with newly synthesized class I molecules and ß2-mi-
croglobulin. TAP is essential because without a source of 
peptides the class I molecules remain unstable and will not 
exit the ER [1]. This results in a dramatic decrease in the cell 
surface expression of class I molecules, as has been revealed 
by cells which harbor TAP mutations [2,3], or in cells where 
TAP expression has been down-regulated [4]. Without MHC 
class I expression viral-infected cells or tumor cells cannot be 
recognized and destroyed by CD8+ cytotoxic T cells, leading 
to unchecked viral infection and tumor growth. 
TAP is a member of the ATP-binding cassette (ABC) fam-
ily of transporters, which include the multidrug resistance P-
glycoprotein (MDR) [5], the cystic fibrosis transmembrane 
conductance regulator (CFTR) [6], and the mating factor 
transporter in yeast (STE6) [7]. Consistent with the other 
transporters in this family, the TAP complex possesses 2 
ATP-binding domains and is predicted to possess 12 mem-
brane spanning regions. TAP is expressed as a heterodimer 
of 2 subunits called TAP.l and TAP.2, which must associate 
in order to form a functional transporter [8]. Until now the 
study of TAP structure and function has been limited to TAP 
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in intact cellular membranes, i.e. in permeabilized cells [9,10] 
and microsomes [11,12]. Although these studies have pro-
duced valuable information on how TAP works, in order to 
understand TAP function in greater molecular detail, the 
functional reconstitution of TAP into artificial membranes 
will be necessary. This will facilitate both the structural anal-
ysis of TAP and studies on the mechanism of TAP action. 
The purification and reconstitution of TAP is necessary to 
determine how TAP behaves in isolation, away from the ple-
thora of proteins which interact with TAP, such as MHC class 
I molecules, tapasin, calnexin, and calreticulin [13,14]. Current 
data suggest that TAP can act alone, as peptide transport 
readily takes place in microsomes derived from TAP-express-
ing insect cells, which do not express the associated proteins 
[15]. However, it needs to be determined unequivocally 
whether TAP alone can transport peptides, and this can 
only be done through purification and functional reconstitu-
tion. 
Toward this end we have attempted to functionally recon-
stitute TAP into proteoliposomes. We have been able to suc-
cessfully solubilize and reconstitute TAP into artificial lipid 
membranes and maintain peptide-binding activity. These are 
important steps toward the complete functional reconstitution 
of TAP which would include the reconstitution of peptide 
transport across the liposome membrane. These studies there-
fore provide valuable information toward the reconstitution 
of TAP and a more complete understanding of TAP biology. 
2. Materials and methods 
2.1. Cell culture 
Raji cells, a B-lymphoblastoid line derived from a patient with 
Burkitt's lymphoma [16], were maintained at 37°C in RPMI (GIB-
CO-BRL, Grand Island, NY) supplemented with 10% bovine calf 
serum, 1 mM pyruvate, 2 mM glutamine, and 100 units/ml each of 
penicillin and streptomycin. The TAP-deficient .174 cells [3] were 
grown in IMDM (GIBCO-BRL) supplemented with 10% bovine 
calf serum, 2 mM glutamine, and 100 units/ml each of penicillin 
and streptomycin. 
2.2. Peptides 
B27#3 (RRYQKSTEL) [17] and the photoreactive KB11 
(AKVPLRPMTYKA, with a biotinylated lysine at position 11) were 
synthesized and purified at the Keck Foundation Biotechnology Re-
source Laboratory at Yale University School of Medicine and were 
generously provided by Dr. Peter Cresswell. The peptides were iodi-
nated as previously described [9]. Briefly, 20 nmoles of peptide was 
iodinated using the method of chloramine T, and the unbound iodine 
was removed by gel filtration on a Sephadex G-10 column. The spe-
cific activity of the peptides was 15-50 cpm/fmol. 
2.3. Phospholipids 
Phospholipids were obtained from Avanti Polar Lipids (Alabaster, 
AL). All the phospholipids were supplied in chloroform, except sphin-
gomyelin, which was supplied as a powder. The lipid mixture was 
composed of phosphatidylcholine (1000 mg), phosphatidylethanol-
amine (500 mg), phosphatidylserine (200 mg), and sphingomyelin 
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(200 mg). The lipids were combined and the chloroform was evapo-
rated off under nitrogen gas. The dried phospholipids were subse-
quently washed twice with 20 ml diethyl ether. Finally, the phospho-
lipid mixture was lyophilized to dryness for 6 h, and then resuspended 
in 2 mM 2-mercaptoethanol for a final concentration of 50 mg lipid/ 
ml. The resuspended lipids were stored in aliquots at —80°C. 
2.4. Membrane preparation 
Raji cell pellets were stored at —80°C. The cell pellets were thawed 
and resuspended in a volume of 2 ml/108 cells on ice in Tris—buffered 
saline (TBS) (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.02% NaN3), 
containing the following mixture of protease inhibitors : 500 μΜ phe-
nylmethylsulfonyl fluoride (PMSF), 2 μg/ml aprotinin, 100 mM ben-
zamidine, and 0.7 μg/ml pepstatin. The suspension was spun for 5 min 
at 1000 Xg to pellet the cells which remained intact. The supernatant 
was removed and saved while the pellet was resuspended in a volume 
of 1 ml/108 cells in 10 mM Tris-HCl, pH 7.4, 0.02% NaN3. The 
suspension was clarified for 5 min at lOOOXg as above. The super-
natant from the second extraction was combined with the supernatant 
from the first extraction, and the pooled supernatant fraction was 
spun at high speed (lOOOOOXg) for 45 min at 4°C to isolate the 
membranes. The membranes were prepared fresh the day of the ex-
periment. 
2.5. Membrane solubilization 
Membrane pellets from 108 Raji cells each (4.1 mg total protein) 
were resuspended in 1 ml of phosphate-buffered saline (PBS) (10 mM 
sodium phosphate, pH 7.4, 150 mM NaCl) containing 20% glycerol, 
10% phospholipid mixture (5 mg/ml final concentration), 1 mM di-
thiothreitol (DTT), protease inhibitors as before, and one of the fol-
lowing detergents: 1% Triton X-100, 2% TV-octylglucoside (NOG), 2% 
digitonin, 1.6% CHAPS, 1.6% BigCHAP, or 1.6% cholic acid. The 
mixtures were incubated for 1 h on ice, followed by ultra-centrifuga-
tion at lOOOOOXg for 1 h to remove any unsolubilized material. The 
supernatants, containing the solubilized membrane proteins, were 
used immediately for peptide-binding assays or for incorporation 
into proteoliposomes. Protein determinations were performed using 
the Bio-Rad DC Protein Assay (Hercules, CA). 
2.6. Proteoliposome formation 
One ml of the phospholipid mixture (50 mg/ml) was sonicated to 
translucency using an ultrasonicator (Laboratory Supplies Co., Hicks-
ville, NY). 100 μΐ of the sonicated phospholipids were added to 1 ml 
of the high speed supernatants (2.0 mg total protein) from above, 
containing solubilized TAP, and the mixture was incubated on ice 
for 30 min. Proteoliposomes were formed by diluting the samples 
25-fold in PBS/1 mM DTT and incubating for 30 min at room tem-
perature as previously described [18]. The proteoliposomes were har-
vested by centrifugation at lOOOOOXg for 1 h at 4°C. 
Alternatively, 1 ml of the phospholipid mixture was solubilized in 
2% NOG in PBS for 1 h at room temperature. The solubilized lipids 
were clarified by centrifugation at lOOOOOXg for 30 min at room 
temperature. Liposomes were then formed by diluting the solubilized 
lipid 25-fold in PBS followed by centrifugation at lOOOOOXg for 45 
min at room temperature. The pellet was resuspended in 2 ml PBS 
and used immediately for the formation of proteoliposomes. Proteo-
liposomes were formed by mixing 2 ml of the liposome solution with 
4 ml of solubilized Raji membrane preparation in 1.6% CHAPS (16.5 
mg total protein), followed by dialysis versus 50 ml PBS with the 
addition of 0.5 g detergent-binding beads (SM-2 Biobeads, Bio-Rad, 
Hercules, CA) for overnight at 4°C (with one exchange of fresh buffer 
and Biobeads). The proteoliposomes were harvested by centrifugation 
of the dialysate at lOOOOOXg for 30 min at 4°C. 
2.7. Peptide-binding assays 
2.7.1. Peptide binding to TAP bound to Sepharose beads. Raji 
membranes (from 1X 108 cells, 4.1 mg total protein) were solubilized 
in various detergents as described above. After the high speed spin, 
the supernatants, containing the soluble TAP proteins, were used for 
the peptide-binding assay. Sepharose-CL4B beads (25 μΐ) conjugated 
to the anti-TAP.l monoclonal antibody 148.3 [15] were added to the 
supernatants and allowed to incubate with rotation for 45 min at 4°C. 
The beads were then washed once in 1 ml wash buffer (PBS, 0.5% 
detergent, and 20% glycerol). The beads were resuspended in 1 ml 
binding buffer (PBS, 0.5% detergent, 20% glycerol, and 1 mM 
DTT) and 125I-B27#3 (100 nM) was added and the mixtures were 
allowed to incubate with rotation for 30 min at 4°C. The Sepharose 
beads, containing bound TAP and radiolabeled peptide, were washed 
3 times in wash buffer and counted in the γ-counter (1470 Wizard, 
Wallac, Gaithersburg, MD). 
2.7.2. Peptide binding to TAP in proteoliposomes. Proteoliposome 
pellets, derived from 4.1 mg total membrane protein, were resus-
pended in 500 μΐ intracellular transport (ICT) buffer (50 mM HEPES, 
pH 7.0, 78 mM KC1, 4 mM MgCl2, 8.4 mM CaCl2, 10 mM EGTA, 
1 mM DTT, and 4 mg/ml bovine serum albumin, see [9]). 125I-B27#3 
(100 nM) was added to the proteoliposome suspension and allowed to 
incubate for 20 min on ice. 1 ml of ICT buffer was added to each 
suspension followed by centrifugation at lOOOOOXg for 15 min at 
4°C. The proteoliposomes were washed one more time in 1 ml ICT 
buffer followed by centrifugation for 15 min as above. The washed 
proteoliposome pellets were then counted in the γ-counter. 
2.8. TAP photolabeling in membranes and proteoliposomes 
Membrane pellets (4.1 mg total protein) or proteoliposome pellets 
(derived from 4.1 mg total membrane protein) were resuspended in 
500 μΐ ICT buffer and transferred to 3.5 cm plastic dishes. The photo-
Fig. 1. A: Peptide binding to solubilized TAP bound to Sepharose-
CL4B. Raji membranes (from 1X108 cells, 4.1 mg total protein) 
were solubilized in the detergents indicated. The extracts were clari-
fied by centrifugation at lOOOOOXg, and the supernatants were used 
for the peptide binding assay as described in Section 2. Briefly, the 
samples were incubated with 25 μΐ of Sepharose-CL4B beads conju-
gated to the anti-TAP.l antibody 148.3. The beads were washed to 
remove unbound TAP, and then 125I-B27#3 was added to the 
beads. After washing a second time, bound 125I-B27#3 was quanti-
tated by counting in a γ-counter. The y-axis (cpm) represents the 
level of 125I-B27#3 bound to the 148.3-conjugated Sepharose beads. 
The histograms represent the mean of duplicate points. В : Western 
blot analysis of the supernatant and pellet fractions from the initial 
solubilizations. Identical fractions of Raji membranes (4.0 mg total 
protein) were solubilized by the various detergents as described 
above (digitonin excluded). The extracts were spun at lOOOOOXg 
for 45 min, and the supernatant and pellet fractions were analyzed 
for TAP protein by Western blot. Briefly, supernatant fractions 
were immunoprecipitated with the anti-TAP.2 antibody 435.3 prior 
to 10% SDS-PAGE analysis, while the pellet fractions were analyzed 
directly by SDS-PAGE. Proteins were transferred to Immobilon-P 
membranes, blotted with the 435.3 antibody, and detected by en-
hanced chemiluminescence (ECL) and autoradiography. 
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reactive peptide KB 11-HSAB was used to photolabel TAP as previ-
ously described [8]. 125I-KB11-HSAB (200 nM) was added to the 
dishes, and incubation was carried out in the dark for 30 min on 
ice. The dishes, with tops removed, were exposed to UV light (254 
nm wavelength) for 3 min. The photolabeled membranes or proteoli-
posomes were washed once by addition of 2.5 ml ICT buffer followed 
by centrifugation at 100000Xg for 45 min. Photolabeled membranes 
or proteoliposomes were solubilized in PBS, 1% Triton X-100, 0.5 
mM PMSF, and 5 mM iodoacetamide for 1 h on ice. The samples 
were clarified by centrifugation at 15000Xg for 5 min. The solubilized 
TAP molecules were immunoprecipitated using 5 μg of the anti-TAP.2 
monoclonal antibody 435.3 [19] and 25 μΐ of protein G-Sepharose 
beads (Sigma, St. Louis, MO). The beads were washed three times 
with wash buffer (TBS, pH 7.4, 0.5% Triton X-100), counted in the γ-
counter, and analyzed by SDS-PAGE and autoradiography. 
3. Results 
3.1. Solubilization of TAP with retention of peptide-binding 
activity 
To determine the optimum detergent for use in TAP recon-
stitution studies a series of detergents was tested for their 
capacity to solubilize TAP and still retain TAP peptide-bind-
ing activity. Membrane preparations from the human B-lym-
phoblastoid cell line Raji were solubilized in Triton X-100, 
digitonin, CHAPS, BigCHAP, cholate, and NOG as described 
in Section 2. The solubilized TAP molecules were then immo-
bilized onto anti-TAP.l antibody (148.3) conjugated Sephar-
ose beads and assayed for the binding of 125I-B27#3 peptide 
to the immobilized TAP molecules. The results, shown in Fig. 
1A, revealed that two detergents, namely digitonin and 
CHAPS, retained a significant degree of peptide-binding ac-
tivity compared to the other detergents tested. Of these two 
detergents, CHAPS appeared more promising for use in TAP 
reconstitution studies due to the inherent difficulties in work-
ing with digitonin. 
To determine whether the reduced level of peptide binding 
observed for several of the detergents above, i.e. Triton X-100, 
BigCHAP, cholate, and NOG, was due to poor solubilization 
of TAP by the respective detergents rather than decreased 
TAP peptide-binding capacity, Western blot analysis for 
TAP protein was performed on the supernatant and pellet 
fractions obtained from the initial solubilizations. The results, 
shown in Fig. IB, revealed that indeed cholate and NOG had 
a significantly reduced ability to solubilize TAP (lanes 4 and 
5), whereas Triton X-100, CHAPS and BigCHAP solubilized 
TAP to a much greater degree (lanes 1, 2, and 3). This in-
dicates that the reduced levels of peptide binding by TAP in 
the presence of Triton X-100 and BigCHAP, is most likely 
due to a reduced capacity to bind peptide by the solubilized 
TAP molecules. However, the reduced levels of peptide bind-
ing by TAP in the presence of cholate and NOG may be in 
part due to poor solubilization of TAP. Nevertheless, the data 
support the choice of CHAPS for further use in TAP recon-
stitution studies. It is not clear why the levels of TAP in the 
NOG-solubilized supernatant and pellet fractions were so low, 
however, it should be noted that TAP could be detected in 
NOG-solubilized photolabeled membranes (see Fig. 2A). 
3.2. TAP in proteoliposomes retains photoreactive 
peptide-binding activity 
To illustrate further the capacity of CHAPS to solubilize 
TAP and maintain peptide-binding activity, TAP, in both Raji 
crude membranes and in proteoliposomes, was photolabeled 
using the 125I-KB11-HSAB photoreactive peptide. In one set 
of experimental points Raji membranes were photolabeled 
Fig. 2. A: TAP photolabeling in membranes and proteoliposomes. Raji membranes or proteoliposomes generated from 1X108 cells each (4.1 
mg total protein) were photolabeled with 125I-KB11-HSAB as described in Section 2. After photolabeling, the membrane pellets were solubilized 
in the series of detergents indicated, i.e. NOG, Triton X-100, digitonin, CHAPS, BigCHAP, and cholate, while the proteoliposome pellets were 
all solubilized in 1% Triton X-100. The solubilized TAP molecules were immunoprecipitated with the anti-TAP.2 antibody 435.3 and protein 
G-Sepharose. The precipitated, photolabeled TAP molecules were analyzed by SDS-PAGE (10%) and autoradiography. B: Analysis of TAP-
containing proteoliposomes by sucrose gradient centrifugation. Proteoliposomes were prepared from Raji membranes (8.2 mg total protein) by 
the detergent dilution method. The proteoliposomes were resuspended in 3 ml 30% sucrose (gradient buffer, 50 mM Tris-HCl pH 7.4, 150 mM 
КО Ac, 5 mM MgOAc) and overlayed successively with 3 ml 20%, 10%, and 5% sucrose. The gradient was spun at 150000Xg for 4 h at 4°C. 
Fractions (1 ml) were collected from the top of the gradient, and were analyzed for TAP by immunoprecipitation with the anti-TAP.2 antibody 
435.3, followed by Western blot analysis of the immunoprecipitated samples as described in the legend to Fig. 1. 
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Fig. 3. Peptide binding to proteoliposomes containing TAP. 125I-
B27#3 binding to proteoliposomes made from Raji or TAP-negative 
.174 cell membranes (4.2 mg total protein each) was carried out as 
described in Section 2. A: 125I-B27#3 binding to proteoliposomes 
derived from Raji was carried out in the presence and absence of 
unlabeled B27#3 competitor peptide (50 μΜ). В: 125I-B27#3 bind-
ing to proteoliposomes derived from Raji and .174 membranes was 
performed in the absence of unlabeled B27#3. The y-axis represents 
the level of 125I-B27#3 (cpmXlCT3) bound to the proteoliposomes. 
The histograms represent the mean of duplicate points. 
prior to solubilization in detergent. The same series of deter-
gents as above was used for the solubilization, i.e. NOG, 
Triton X-100, digitonin, CHAPS, BigCHAP, and cholate. In 
another set of points, Raji membranes were first solubilized in 
the detergent series and proteoliposomes generated from the 
solubilized TAP molecules for each detergent. The proteolipo-
somes were in turn photolabeled using the KB 11 photopep-
tide. Photolabeled TAP molecules from all samples were im-
munoprecipitated using the anti-TAP.2 antibody 435.3, and 
analyzed by SDS-PAGE and autoradiography. The results 
of this analysis are shown in Fig. 2A. The detergents in the 
series were more or less successful in solubilizing TAP from 
photolabeled Raji membranes (left panel), especially Triton 
X-100 (lane 2) and CHAPS (lane 4). In contrast, only CHAPS 
generated proteoliposomes which could still bind the peptide 
and photolabel TAP (right panel, lane 10). Clearly, the other 
detergents generated proteoliposomes which had very low or 
no peptide-binding capacity. Surprisingly, digitonin produced 
proteoliposomes with very little peptide-binding capacity (lane 
9) in spite of showing a high level of peptide binding in the 
prior assay (see Fig. 1A). This is most likely due to its poor 
ability to form proteoliposomes. The results unambiguously 
show that CHAPS is the detergent of choice for the genera-
tion of proteoliposomes containing TAP with retention of 
peptide-binding activity, and CHAPS is utilized for the re-
mainder of this study. 
To confirm that the proteoliposomes generated in this study 
were in fact proteoliposomes and not aggregated/high density 
protein/lipid complexes, a sample of the proteoliposomes gen-
erated from Raji membranes was run on a sucrose density 
gradient. TAP-containing liposomes were subsequently immu-
noprecipitated from the fractions and analyzed by Western 
blot analysis. As revealed in Fig. 2B, the TAP-containing 
fractions (predominantly fractions 7 and 8) were found ap-
proximately two-thirds of the way into the gradient of 5% to 
30% sucrose, and did not appear to migrate as high density 
protein/lipid aggregates. This indicates that liposomes con-
taining TAP were formed during the TAP reconstitution pro-
cedure. 
3.3. TAP in proteoliposomes specifically binds 1251-labeled 
peptides 
The ultimate goal of these studies is to reconstitute peptide 
transport, and in this sense the use of photoreactive peptides 
to measure peptide binding was prohibitive. Therefore we 
tested the proteoliposomes for their capacity to bind 125I-
B27#3. Shown in Fig. 3 are the results of peptide binding 
to reconstituted TAP in liposomes in the absence and presence 
of excess unlabeled B27#3 (Fig. ЗА), and 125I-B27#3 binding 
to proteoliposomes generated from Raji and the TAP-negative 
cell line .174 (Fig. 3B). The results indicate that 125I-B27#3 
binding to proteoliposomes is specific. The binding was com-
peted with excess unlabeled peptide, and peptide binding to 
TAP-negative proteoliposomes (.174) was much lower in com-
parison to TAP-positive proteoliposomes (Raji). The high lev-
el of background binding is most likely due to the sticky 
nature of the proteoliposomes, and measures to reduce the 
level of background binding are being explored. Saturation 
peptide-binding analysis was also performed on TAP recon-
stituted into proteoliposomes. The results, shown in Fig. 4, 
reveal that 125I-B27#3 binding to proteoliposomes is satura-
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Fig. 4. Saturation binding of 125I-B27#3 to proteoliposomes. 125I-
B27#3 binding to proteoliposomes derived from Raji membranes 
(2.0 mg total membrane protein per point) was performed at differ-
ent concentrations of the labeled peptide (x-axis). Each point repre-
sents the mean of peptide binding to duplicate samples with the 
background binding (amount of 125I-B27#3 bound in the presence 
of 100 μΜ unlabeled B27#3) subtracted. 
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ble. The estimated maximum bound peptide (Bmsx) was ap-
proximately 5 pmols which directly relates to the amount of 
active TAP. In addition, the KU of the binding reaction was 
~ 150 nM, which is consistent with previous data on peptide 
binding to TAP in microsomes [20]. 
4. Discussion 
The reconstitution of TAP into proteoliposomes is impor-
tant for further structural and functional analysis of TAP. A 
key step in this procedure is the solubilization of TAP in 
detergent with the retention of TAP activity. This type of 
analysis is purely empirical and can only be done by testing 
different detergents. We were able to show that CHAPS is the 
detergent of choice for TAP reconstitution experiments. Pep-
tide binding to TAP solubilized in CHAPS (Fig. 1), as well as 
photoaffinity labeling of TAP solubilized in CHAPS and in-
corporated into proteoliposomes (Fig. 2), clearly shows that 
CHAPS retains the highest level of pep tide-binding activity. 
Digitonin also retained a certain level of TAP activity, how-
ever, due to the inherent problems with working with digito-
nin, it was not chosen for further use. Although CHAPS may 
not be the most efficient detergent for solubilizing membranes, 
the fact that it retains TAP peptide-binding activity while the 
other detergents do not is a critical factor. In fact, based upon 
the Western analysis shown in Fig. 1, CHAPS is able to solu-
bilize approximately 50% of the TAP molecules associated 
with the original membranes, and based upon the maximum 
level of peptide binding to proteoliposomes in Fig. 4, this 
represents a minimum of 750 ng TAP per 2.0 mg total mem-
brane protein. 
A prerequisite for the reconstitution of peptide transport 
via TAP incorporated into proteoliposomes is the successful 
reconstitution of peptide binding to TAP. We have been able 
to reconstitute peptide binding to TAP in proteoliposomes. As 
shown in Fig. 3 this peptide binding is specific. It is competed 
by unlabeled competitor peptide (Fig. ЗА), and the labeled 
peptide binds very poorly to proteoliposomes derived from 
TAP-negative membranes (Fig. 3B). With the conditions for 
peptide binding worked out, peptide transport experiments 
were undertaken. These were done by adding ATP and la-
beled peptide to proteoliposomes followed by incubation at 
37°C to allow for the incorporation of the peptide into the 
liposomes. Unfortunately, the level of peptide incorporation 
in the presence of ATP was only slightly above the level of 
incorporation in the absence of ATP (data not shown). There-
fore, the state of TAP in the proteoliposomes, although good 
enough to allow for peptide binding, does not appear to sup-
port peptide transport, and further refinement of the recon-
stitution system will be required. 
Another aspect of TAP reconstitution is the purity of TAP. 
We have chosen to pursue the functional reconstitution of 
TAP using proteoliposomes prepared from crude cellular 
membranes. B-lymphoblastoid cell lines such as Swei and 
Raji produce relatively large amounts of TAP, and provide 
a good source of material for reconstitution studies. In addi-
tion, membranes from the B-lymphoblastoid lines are easily 
prepared, and may contain the necessary TAP-associated pro-
teins or cofactors to facilitate peptide transport. Our strategy 
is to first define the conditions for peptide transport in pro-
teoliposomes derived from crude cellular membranes, and 
once these conditions have been worked out, attempt to re-
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constitute using purified TAP. In this way, the number of 
experimental variables will be kept to a minimum at each 
step. Ultimately, one will have to utilize a TAP overexpression 
system, i.e. baculovirus, to generate enough protein to purify 
TAP successfully. 
The reconstitution of peptide transport by TAP remains a 
challenge for future studies. The related ABC transporters, 
multidrug resistance P-glycoprotein (MDR) and the cystic 
fìbrosis transmembrane conductance regulator (CFTR) have 
been successfully purified and reconstituted [21-23]. Neverthe-
less, substrate transport in the reconstituted systems has prov-
en difficult to show. For P-glycoprotein the vast majority of 
reports on functional reconstitution have involved the resto-
ration of drug-induced ATPase activity and not drug trans-
port [24]. The main problem is that the hydrophobic nature of 
MDR substrates results in high non-specific binding to pro-
teoliposomes, and lack of accumulation in vesicles. Further-
more, CFTR is considered a regulated chloride channel and 
therefore the transport properties of CFTR are fundamentally 
different from those of P-glycoprotein and TAP. In the case of 
TAP, the peptide transport process is inherently more com-
plex than peptide binding. For example, peptide transport 
requires the binding and hydrolysis of ATP, the translocation 
of the peptide across the lipid bilayer, and the accumulation 
of the peptide within the liposome. All these factors will need 
to be addressed to achieve successful peptide transport in a 
reconstituted system. 
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